Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029316 | SCV000051962 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Likely benign. |
Counsyl | RCV000029316 | SCV000220138 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2014-03-03 | criteria provided, single submitter | literature only | |
Labcorp Genetics |
RCV000029316 | SCV000629958 | benign | Polyglandular autoimmune syndrome, type 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818184 | SCV002067888 | benign | not specified | 2021-04-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000029316 | SCV002801166 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004546415 | SCV005041625 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | AIRE: BS1, BS2 |
Breakthrough Genomics, |
RCV004546415 | SCV005207500 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000029316 | SCV001460107 | benign | Polyglandular autoimmune syndrome, type 1 | 2020-06-17 | no assertion criteria provided | clinical testing |